3/25/2026Innovent Eyes China Approval as IBI302 Matches Eylea in Phase 3 nAMD S...

3/25/2026China Seeks Public Input on Accelerating National Drug Traceability Sy...

3/25/2026China Suspends Imports of Select Indian APIs Over GMP Violations

3/25/2026BrightGene Reports Positive Phase 1 Data for Oral GLP-1/GIP Weight-Los...

3/25/2026Castalysis Secures Pre-A Funding to Advance alphaCas Gene Editing Plat...

3/25/2026Cellgenes Raises CNY 100M+ Pre-C to Advance Stem Cell Therapy Pipeline

3/25/2026Insilico Launches PandaClaw to Streamline AI-Driven Drug Discovery

3/25/2026Gilead Nears $2B Ouro Deal Anchored by China-Origin BCMA/CD3 Asset

3/25/2026Innovent Reports Positive Phase 3 STAR Results for IBI302 in nAMD

3/25/2026Hope Medicine Advances HMI-115 Into Phase III for Endometriosis

3/24/2026LG Chem's Tigulixostat Advances to Phase 3 in China Through Innovent P...

More>>

3/25/2026IQVIA Report Highlights Rising Use and Intensifying Competition in Chi...

3/24/2026Global Pharma Ramps Up China Investment as 15th Five-Year Plan Priorit...

3/17/2026US Reshoring Push Clouds Long-Term Outlook for China's Contract Drugma...

3/17/2026China to Grant Market and Data Exclusivity for Innovative Drugs for th...

3/13/2026China Private Biotech Financing Slows in February but Larger Deals Sig...

3/12/2026China's Labs Race for the Next First-in-Class Breakthrough

3/10/2026China Challenges High-Priced Gene Therapies with Lower-Cost Alternativ...

3/10/2026China Biotech Dealmaking Defies Seasonal Slowdown as February Licensin...

3/10/2026US Weighs Policy Measures to Address China Biotech Competition

3/9/2026China Biotech Financing Rebounds in Early 2026 as RNA Deals and Global...

3/4/2026China Biotech Outlicensing Surges Past US$52 Billion in Early 2026

More>>